Nonadherence to Statin Therapy: Discontinuation After a Single Fill

Canadian Journal of Cardiology

Volumn 28, Issue 5, 2012, Pages 567-573

  Lemstra, Mark ^a   Blackburn, David ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SASKATCHEWAN; SEX FACTORS;

EID: 84866366696     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.03.018     Document Type: Article

References (24)

1. Rasmussen J.N., Chong A., Alter Da Relationship between adherence to evidence based pharmacotherapy and long term mortality after acute myocardial infarction. JAMA 2007, 297:177-186.
2. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
3. Schedlbauer A., Davies P., Fahey T. Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 2010, 3. CD004371.
4. Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., Avorn J. Long term persistence in use of statin therapy in elderly patients. JAMA 2002, 288:455-461.
5. May C., Montori V., Mair F. We need minimally disruptive medicine. BMJ 2009, 339:485-487.
6. Ting H.H., Shojania K.G., Montori V.M., Bradley E.H. Quality improvement: science and action. Circulation 2009, 119:1962-1974.
7. Pedan A., Varasteh L.T., Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchal model considering physician, pharmacy, patient and prescription characteristics. J Manag Care Pharm 2007, 13:487-496.
8. Karter A.J., Parker M.M., Moffet H.H., Ahmed A.T., Schmittdiel J.A., Selby J.V. New prescription medication gaps: a comprehensive measure of adherence to new medications. Health Serv Res 2009, 44:1640-1661.
9. Ho P.M., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 2006, 166:1842-1847.
10. Downey W., Stang M., Beck P., Osei W., Nichol J. Health services databases in Saskatchewan. Pharacoepidemiology 2005, 295-310. Wiley, Chicester, UK. 4th ed. B.L. Strom (Ed.).
11. International statistical classification of diseases and related health problems. 10th rev 2010, World Health Organization, Author, Geneva, Switzerland.
12. Varas-Lorenzo C., Castellsague J., Stang M.R., Tomas L., Aguado J., Perez-Gutthann S. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndrome in the Saskatchewan hospital automated database. Pharmacotherapy Drug Safety 2008, 17:842-852.
13. Suissa S., Ernst P., Benayoun S., Baltzan M., Cai B. Low-dose inhaled corticosteroids and the prevention of deaths from asthma. N Engl J Med 2000, 343:332-336.
14. Blackburn D.F., Lamb D.A., Eurich D.T., Johnson J.A., Wilson T.W., Dobson R.B., et al. Atenolol as initial antihypertensive therapy: an observational study comparing first line agents. J Hypertens 2007, 25:1499-1505.
15. Blackburn D.F., Dobson R.T., Blackburn J.L., Wilson T.W. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy 2005, 25:1035-1043.
16. Lamb D.A., Eurich D.T., McAlister F.A., et al. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure. Circ Cardiovasc Qual Outcomes 2009, 2:228-235.
17. Larsen J., Andersen M., Kragstrup J., Gram L. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol 2002, 53:375-378.
18. Von Korff M., Wagner E., Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992, 45:197-203.
19. Rothman K.J., Greenland S. Modern Epidemiology 1998, Lippincott Williams and Wilkins, Philadelphia, PA. 2nd ed.
20. Hosmer D.W., Lemeshow S. Applied Logistic Regression 1989, Wiley, New York, NY.
21. Evans C.D., Eurich D.T., Remillard A.J., Shevchuk Y.M., Blackburn D. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens 2012, 25:195-203.
22. Katz P.M., Mendelson A.A., Goodman S.G., Langer H., Leiter L.A. Use of a treatment optimization involving statin ezetimibe combination aids in achievement of guidance based low density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC). Can J Cardiol 2011, 27:138-145.
23. Meichenbaum D., Turk D.C. Facilitating Treatment Adherence: A Practitioner's Guidebook 1987, Plenum, New York.
24. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002, 288:462-467.